Orange Book product · Generic (ANDA)
LEUCOVORIN CALCIUM
LEUCOVORIN CALCIUM
At a glance
Dec 15, 1999
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 15, 1999
26 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
LEUCOVORIN CALCIUM
Strength
EQ 350MG BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 040262
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LEUCOVORIN CALCIUM
- 2026VYKOURABrand (NDA)
NDA 220406 · AVYXA HOLDINGS
- 1987LEUCOVORIN CALCIUMBrand (NDA)
NDA 008107 · HOSPIRA
- 2025LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 218200 · GLAND
- 2023LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 216590 · MEITHEAL
- 2023LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 217021 · HAINAN POLY
- 2020LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 213929 · LEADING
- 2020LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 211132 · INGENUS PHARMS LLC
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 210917 · INGENUS PHARMS LLC
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207226 · FRESENIUS KABI USA
- 2018LEUCOVORIN CALCIUMGeneric (ANDA)
ANDA 207241 · FRESENIUS KABI USA
- 2017LEUCOVORIN CALCIUM PRESERVATIVE FREEGeneric (ANDA)
ANDA 209110 · SAGENT PHARMS INC
- 2017LEUCOVORIN CALCIUM PRESERVATIVE FREEGeneric (ANDA)
ANDA 203800 · MYLAN LABS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
